Study to Evaluate the Efficiency of FOLFIRI as Seconde-line Chemotherapy in Neuroendocrine Carcinoma
Clinical trial NCT03168607 · UNKNOWN
Trial details
- NCT number
- NCT03168607
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-02
- Primary completion
- 2019-05-02
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.